Cutaneous T-cell lymphoma

5 total trials MedDRA PT

Filter these 5 trials by phase, country, sponsor and more.

Open in Search →

CITY Pending

2024-520294-13-00 1 "Cutaneous T-cell lymphomas (CTCL)"
BeCALM - Brentuximab vedotin in CutAneous T-cell Lymphomas (CTCL): post-allogeneic hematopoietic stem cell transplant Maintenance Pending

2025-521093-34-00 5 "rare disease"
A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma Pending

2025-522523-96-00 1 "T-cell Non-Hodgkin Lymphoma"
A safety study of PF-08046045/SGN-35T in adults with advanced cancers Ended

2022-502390-41-00 1 2024-06-20 "Enteropathy-Associated T-Cell Lymphoma"
Study of the safety, activity, and effect on the body of ASTX660 in people with advanced cancers. Ended

2024-516679-33-00 7 2017-12-01 "Advanced Solid Tumors and Lymphomas that are metastatic or u"

Showing 1–5 of 5 trials